Related Experiment Video
Updated: Aug 13, 2026

Gastrointestinal Motility Monitor (GIMM)
Published on: December 2, 2010
Alpha-2 agonists induce amnesia through activation of the Gi-protein signalling pathway
N Galeotti1, A Bartolini, C Ghelardini
1Department of Preclinical and Clinical Pharmacology, Viale G. Pieraccini 6, I-50139 Florence, Italy.
Abstract:
The post-receptorial mechanism of the amnesic action of the alpha2-agonists clonidine and guanabenz was investigated in the mouse passive avoidance test. Animals were i.c.v. injected with pertussis toxin (PTX) or with antisense oligonucleotides, complementary to the sequence of the alpha-subunit mRNA of Gi1, Gi2, Gi3, Go1 and Go2 proteins. The administration of PTX (0.25 microg per mouse i.c.v.) reversed the amnesia induced by both alpha2-agonists. Similarly, anti-Gialpha1 (6.25-12.5 microg per mouse i.c.v.), anti-Gialpha3 (3.12-12.5 microg per mouse i.c.v.), anti-Goalpha1 (12.5-25 microg per mouse i.c.v.) antagonised the detrimental effect induced by clonidine and guanabenz. By contrast, pretreatment with anti-Gialpha2 (3.12-25 microg per mouse i.c.v.) and anti-Goalpha2 (12.5-25 microg per mouse i.c.v.) never modified the impairment of memory processes induced by the alpha2-agonists. At the highest effective doses, none of the compounds used impaired motor coordination (rota rod test), nor modified spontaneous motility and inspection activity, (hole board test). These results indicate the involvement of Gi1, Gi3, and Go1, but not Gi2 and Go2, protein subtypes in the transduction mechanism responsible for the induction of amnesia by clonidine and guanabenz.
Insights
The study investigated how alpha2-agonists cause amnesia in mice. Pertussis toxin and specific antisense oligonucleotides revealed that Gi1, Gi3, and Go1 proteins are involved in this memory impairment.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Alpha2-adrenergic agonists like clonidine and guanabenz can induce amnesia.
- The precise post-receptorial mechanisms underlying this amnesic effect are not fully understood.
- G-protein signaling pathways are crucial in mediating cellular responses to various stimuli.
Purpose of the Study:
- To elucidate the specific G-protein subtypes involved in the amnesic action of clonidine and guanabenz.
- To investigate the post-receptorial transduction mechanisms of alpha2-agonist-induced memory impairment.
Main Methods:
- Mice were subjected to a passive avoidance test to assess memory.
- Intracerebroventricular (i.c.v.) injections of pertussis toxin (PTX) were used to inhibit G-protein function.
- Antisense oligonucleotides targeting specific alpha-subunits of Gi and Go proteins (Gi1, Gi2, Gi3, Go1, Go2) were administered.
- Motor coordination and spontaneous activity were evaluated using the rota rod and hole board tests, respectively.
Main Results:
- Pertussis toxin administration reversed the amnesia induced by both clonidine and guanabenz.
- Antisense oligonucleotides against Gi1, Gi3, and Go1 alpha-subunits antagonized the amnesic effects.
- Antisense oligonucleotides against Gi2 and Go2 alpha-subunits did not affect the memory impairment.
- No tested compound affected motor coordination or spontaneous behavior.
Conclusions:
- The findings indicate that Gi1, Gi3, and Go1 protein subtypes are critically involved in the amnesic effects of clonidine and guanabenz.
- Gi2 and Go2 protein subtypes do not appear to play a significant role in this specific memory impairment.
- This study clarifies the molecular pathways mediating alpha2-agonist-induced amnesia, highlighting specific G-protein involvement.
Related Concept Videos
Activation and Inactivation of G Proteins
GPCR Desensitization
GPCRs Regulate Adenylyl Cylase Activity
Two...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...

